Virbac SA

Historical price data

Virbac is a leading independent animal health company with a mission to improve the health and well-being of animals through innovative pharmaceutical solutions. Founded in 1968, it has grown into a global organization with a direct commercial presence in major markets and a diverse portfolio spanning pharmaceuticals, biologicals, and nutritional supplements. The company's strategy focuses on internal R&D, strategic acquisitions, and geographic expansion, particularly in emerging markets, to drive sustainable growth in the dynamic veterinary health sector.

Integrated R&D and manufacturing capabilities across veterinary pharmaceuticals, biologicals/vaccines, and nutritional supplements, without a single proprietary platform.

Virbac competes with giants like Zoetis, Merck, and Elanco, but differentiates itself through its independent, veterinary-focused structure, strong leadership in dermatology, a balanced portfolio between companion animals and livestock, and a direct commercial presence in many countries, providing greater control and customer proximity.